Cargando…
NADPH oxidases and HIF1 promote cardiac dysfunction and pulmonary hypertension in response to glucocorticoid excess
Cardiovascular side effects are frequent problems accompanying systemic glucocorticoid therapy, although the underlying mechanisms are not fully resolved. Reactive oxygen species (ROS) have been shown to promote various cardiovascular diseases although the link between glucocorticoid and ROS signali...
Autores principales: | Kračun, Damir, Klop, Mathieu, Knirsch, Anna, Petry, Andreas, Kanchev, Ivan, Chalupsky, Karel, Wolf, Cordula M., Görlach, Agnes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226895/ https://www.ncbi.nlm.nih.gov/pubmed/32413743 http://dx.doi.org/10.1016/j.redox.2020.101536 |
Ejemplares similares
-
The NADPH Oxidase Subunit NOX4 Is a New Target Gene of the Hypoxia-inducible Factor-1
por: Diebold, Isabel, et al.
Publicado: (2010) -
MicroRNAs in the Regulation of NADPH Oxidases in Vascular Diabetic and Ischemic Pathologies: A Case for Alternate Inhibitory Strategies?
por: Wallace, Sean R., et al.
Publicado: (2022) -
NADPH Oxidase Isoforms Are Involved in Glucocorticoid-Induced Preosteoblast Apoptosis
por: Bai, Shu-Cai, et al.
Publicado: (2019) -
HIF-1α Activation by Intermittent Hypoxia Requires NADPH Oxidase Stimulation by Xanthine Oxidase
por: Nanduri, Jayasri, et al.
Publicado: (2015) -
NADPH Oxidase: a Target for the Modulation of the Excessive Oxidase Damage Induced by Overtraining in Rat Neutrophils
por: Dong, Jingmei, et al.
Publicado: (2011)